Reported / Citable
Background
Charles Terrence Bruff, a USAA software engineer who receives Medicare and Medicaid benefits, brought a qui tam action alleging that USAA and pharmacy benefit managers Caremark, OptumRx, and Express Scripts failed to coordinate prescription-drug coverage properly. He claimed that Medicare or Medicaid paid expenses that USAA’s large group health plan should have paid and that the defendants failed to reimburse the government.
Bruff asserted direct and reverse False Claims Act theories based on alleged violations of the Medicare Secondary Payer Act. USAA, Caremark, and Optum moved to dismiss the first amended complaint. Express Scripts had not appeared and did not join the motions.
The Court’s Holding
The court dismissed the claims against Optum without prejudice for lack of Article III standing. The complaint mentioned Optum only sparsely and alleged no conduct connecting it to any injury suffered by Bruff or the United States.
The court held that Bruff adequately alleged standing as to USAA and Caremark but failed to state an FCA claim against them. The Medicare Secondary Payer Act separately authorizes the United States to sue on its own behalf and private individuals to sue on their own behalf; Bruff could not use the FCA to pursue the government’s MSP claims. His reverse-FCA theory also failed because he did not allege an established obligation owed to the government, as opposed to a contingent possibility of future liability.
The allegations additionally failed Rule 9(b)’s particularity requirement. Bruff did not identify specific false claims, responsible individuals, communications, dates, or other details showing knowing fraud. The court therefore dismissed all claims against USAA and Caremark without prejudice. It did not dismiss Express Scripts, but warned that failure to seek default could result in dismissal for failure to prosecute.
Key Takeaways
- A relator must connect each defendant’s conduct to a concrete injury; naming a defendant and making generalized industry allegations does not establish standing.
- An alleged statutory violation or potential penalty is not, without more, an established payment obligation supporting a reverse False Claims Act claim.
- False Claims Act allegations must satisfy Rule 9(b) by providing particularized facts about the alleged fraud, including who acted, what occurred, and when and where it happened.
Why It Matters
The decision limits attempts to repackage Medicare Secondary Payer Act disputes as qui tam FCA actions. Where Congress has supplied distinct government and private enforcement mechanisms, a private plaintiff cannot assume the government’s MSP claim merely by pleading it under the FCA.
It also underscores that sweeping estimates of government losses cannot substitute for defendant-specific allegations establishing standing, a present obligation to pay, and knowing misconduct pleaded with particularity.